As of today (2024-04-25), VolitionRX's share price is $0.80. VolitionRX's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $-0.10. Hence, VolitionRX's Price to Tangible Book Ratio of today is .
The historical rank and industry rank for VolitionRX's Price-to-Tangible-Book or its related term are showing as below:
During the past 13 years, VolitionRX's highest Price to Tangible Book Ratio was 15.79. The lowest was 5.48. And the median was 9.52.
VNRX's Price-to-Tangible-Book is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.45 * Ranked among companies with meaningful Price-to-Tangible-Book only.
A closely related ratio is called PB Ratio. As of today, VolitionRX's share price is $0.80. VolitionRX's Book Value per Sharefor the quarter that ended in Dec. 2023 was $-0.10. Hence, VolitionRX's P/B Ratio of today is .
VolitionRX Price-to-Tangible-Book Historical Data
The historical data trend for VolitionRX's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of VolitionRX's Price-to-Tangible-Book
For the Diagnostics & Research subindustry, VolitionRX's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VolitionRX's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, VolitionRX's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where VolitionRX's Price-to-Tangible-Book falls into.
VolitionRX Price-to-Tangible-Book Calculation
VolitionRX's price-to-tangible-book ratio for today is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
VolitionRX Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of VolitionRX's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
VolitionRX Ltd is a United states based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VNRX has been successfully added to your 